Evidence map›Paper›PMID 25662839›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Reward Responsiveness Varies by Smoking Status in Women with a History of Major Depressive Disorder.

Amy C Janes, Paola Pedrelli, Alexis E Whitton, Pia Pechtel, Samuel Douglas, Max A Martinson, Ilana Huz, Maurizio Fava, Diego A Pizzagalli, A Eden Evins

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Depression Severity Moderates Reward Learning Among Smokers With Current or Past Major Depressive Disorder in a Smoking Cessation Randomized Clinical Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Trial
  2. Trial
  3. Nicotine normalizes cortico-striatal connectivity in non-smoking individuals with major depressive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Electrophysiological signatures of reward learning in the rodent touchscreen-based Probabilistic Reward Task.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  11. A cross-species assay demonstrates that reward responsiveness is enduringly impacted by adverse, unpredictable early-life experiences.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  12. Anhedonia in Nicotine Dependence.Current topics in behavioral neurosciences · 2022
    Review
  13. Translational Assessments of Reward Responsiveness in the Marmoset.The international journal of neuropsychopharmacology · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Association Between Reward Reactivity and Drug Use Severity is Substance Dependent: Preliminary Evidence From the Human Connectome Project.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Amy C Janes1] McLean Imaging Center, McLean Hospital, Harvard Medical School, Belmont, MA, USA [2] Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Paola Pedrelli1] Department of Psychiatry, Harvard Medical School, Boston, MA, USA [2] Depression Clinical Research Program, Massachusetts General Hospital, Boston, MA, USA.
Alexis E Whitton1] Department of Psychiatry, Harvard Medical School, Boston, MA, USA [2] Center for Depression, Anxiety and Stress Research, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
Pia Pechtel1] Department of Psychiatry, Harvard Medical School, Boston, MA, USA [2] Center for Depression, Anxiety and Stress Research, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
Samuel DouglasCenter for Depression, Anxiety and Stress Research, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
Max A MartinsonDepression Clinical Research Program, Massachusetts General Hospital, Boston, MA, USA.
Ilana HuzDepression Clinical Research Program, Massachusetts General Hospital, Boston, MA, USA.
Maurizio Fava1] Department of Psychiatry, Harvard Medical School, Boston, MA, USA [2] Depression Clinical Research Program, Massachusetts General Hospital, Boston, MA, USA.
Diego A Pizzagalli1] McLean Imaging Center, McLean Hospital, Harvard Medical School, Belmont, MA, USA [2] Department of Psychiatry, Harvard Medical School, Boston, MA, USA [3] Depression Clinical Research Program, Massachusetts General Hospital, Boston, MA, USA [4] Center for Depression, Anxiety and Stress Research, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
A Eden Evins1] Department of Psychiatry, Harvard Medical School, Boston, MA, USA [2] Center for Addiction Medicine, Massachusetts General Hospital, Boston, MA, USA.
Harvard University · USMassachusetts General Hospital · USImaging Center · USMcLean Hospital · US

Funding

Neuroimaging Studies of Reward Processing in DepressionR37MH068376 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI Diego A Pizzagalli · 2016 to 2026
$7.4M
Neuroimaging Studies of Reward Processing in DepressionR01MH068376 · NIMH · MCLEAN HOSPITAL · PI PIZZAGALLI, DIEGO A · 2004 to 2014
$4.5M
Drug Discovery Group for Nicotine Dependence TreatmentU01DA019378 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI FAVA, MAURIZIO · 2004 to 2010
$3.2M
Mentoring in Addiction Treatment ResearchK24DA030443 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI EVINS, A EDEN · 2010 to 2020
$2.0M
Enhanced Treatment for Binge Drinking Depressed College StudentsK23AA020064 · NIAAA · MASSACHUSETTS GENERAL HOSPITAL · PI PEDRELLI, PAOLA · 2011 to 2015
$880k
Training in Cognitive Function and Neuroimaging of Smoking-Related CuesK01DA029645 · NIDA · MCLEAN HOSPITAL · PI JANES, AMY C · 2011 to 2015
$853k
Translational Measures of anhedonia in humans and ratsR21MH078979 · NIMH · MCLEAN HOSPITAL · PI PIZZAGALLI, DIEGO A · 2008 to 2009
$430k
NIAAA NIH HHS K23 AA020064NIAAA NIH HHS K23AA020064NIDA NIH HHS K01 DA029645NIDA NIH HHS K01DA029645NIDA NIH HHS K24 DA030443NIDA NIH HHS K24DA030443NIDA NIH HHS U01 DA019378NIDA NIH HHS U01DA019378NIMH NIH HHS R01 MH068376NIMH NIH HHS R01MH068376NIMH NIH HHS R10MH68376NIMH NIH HHS R21 MH078979NIMH NIH HHS R21MH078979
6 · The paper itself

Abstract

Major depressive disorder (MDD) and nicotine dependence are highly comorbid, with studies showing that ~50% of individuals with MDD smoke. The link between these disorders persists even after the clinical symptoms of depression subside, as indicated by high levels of nicotine dependence among individuals with remitted depression (rMDD). Recent evidence indicates that individuals with rMDD show blunted responses to reward as measured by a probabilistic reward task (PRT), which assesses the ability to modify behavior as a function of reward history. Given nicotine's ability to enhance reward responsiveness, individuals with rMDD might smoke to address this persistent reward deficit. However, it is unclear whether smokers with rMDD show enhanced reward responsiveness relative to rMDD individuals who do not smoke. To test this hypothesis, we evaluated reward responsiveness on the PRT in four groups (N=198): individuals with and without rMDD who were or were not nicotine dependent. As hypothesized, rMDD nonsmokers had lower reward responsiveness relative to both control nonsmokers and rMDD smokers; conversely, smokers with rMDD showed behavioral patterns comparable to those without a history of depression. Given nicotine's ability to enhance reward sensitivity, it is possible that nicotine normalizes the otherwise blunted reward responsiveness in individuals with rMDD. Therapies aimed at enhancing this reward-based deficit may be beneficial in the treatment of both nicotine dependence and MDD.

Indexed as

RewardAdolescentAdultBiasDiscriminant AnalysisFemaleHumansLearning DisabilitiesMajor Depressive DisorderMiddle AgedPsychiatric Status Rating ScalesReaction TimeSmokingYoung Adult

Identifiers

PMID25662839
PMCPMC4839517
OpenAlexW2079397521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.